Validogen GmbH

VALIDOGEN GmbH is a contract research and development organization specializing in recombinant protein expression using its proprietary UNLOCK PICHIA platform. The company utilizes the yeast Pichia pastoris (Komagataella phaffii) to develop high-performance production strains and scalable fermentation and protein purification processes. Their approach involves high-throughput screening and the generation of diverse genetic constellations to optimize protein yields and quality. By maintaining a specialized focus on Pichia technology and offering customizable project setups, the company distinguishes itself through deep scientific expertise and tailored service offerings that address specific protein manufacturing challenges.

Serving industries such as biopharma, food and feed, industrial biotechnology, and diagnostics, VALIDOGEN supports clients from initial feasibility studies to technology transfer for industrial-scale manufacturing. Their services facilitate the development of biopharmaceuticals and enzymes, with outputs that have been successfully integrated into clinical studies and industrial applications. Headquartered in Austria, the company leverages over 15 years of experience to provide robust, reproducible processes that help partners navigate complex regulatory requirements, ensuring that developed strains and protocols are suitable for commercial production environments.